Gilead Sciences, Inc (GILD) Sec Form 8K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 8K
AlphaGraphs
Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues
Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, has reported a decline in adjusted earnings for the fourth quarter...
Gilead Sciences, Inc (GILD) Dividend Update
Gilead Sciences, Inc (NASDAQ: GILD) Q1 2026 Dividend Update
Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call
Gilead Sciences, Inc (NASDAQ: GILD) Q4 2025 Earnings Conference
ADVERTISEMENT
Gilead Sciences, Inc (GILD) FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…
Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…
AlphaGraphs
Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up 5% year-over-year. Net income attributable…
ADVERTISEMENT
AlphaGraphs
Gilead Sciences (GILD) Earnings: 1Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down 4% year-over-year. Net income attributable…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when its revenues moved…